1st and 9th floor, Ashoka Estate, 24 Barakhamba Road,
New Delhi 110 001
India
+91-11-4121 5100
www.luthra.com
delhi@luthra.com
Luthra & Luthra is an Indian full service legal firm focused on providing legal advice and assistance to clients. The Firm's practice areas include arbitration, banking and finance, capital markets and securities law, competition/antitrust law, corporate, mergers and acquisitions, dispute resolution, intellectual property, private equity, and tax. The Firm’s sector experience includes aerospace, construction, education, energy services, environmental, financial services, healthcare services, infrastructure, insurance, life science, and real estate. Luthra & Luthra was established in 1990 and is based in New Delhi.
Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T |
---|---|---|---|---|---|---|---|
Buyside (0.0/yr) | 1 | - | - | - | - | - | 1 |
Sellside (0.0/yr) | 2 | - | - | - | - | - | 2 |
3 |
Target Company | Date | Value | Type |
---|---|---|---|
Sign-up to View | 2018-08-02 | 212M USD | Healthcare Services |
Sign-up to View | 2016-10-13 | - | Metals/Mining |
Sign-up to View | 2014-04-04 | 4.0B USD | Life Science |
View All >> |
Sector | # | Value | |
---|---|---|---|
Life Science | Sign-up to View | ||
Healthcare Services | Sign-up to View | ||
Metals/Mining | Sign-up to View | ||
Total | Sign-up to View |
State/Country | # | Value | |
---|---|---|---|
India | Sign-up to View | ||
United States | Sign-up to View | ||
Domestic | Sign-up to View | ||
Cross-border | Sign-up to View | ||
Total | Sign-up to View |
Type | # | Value | |
---|---|---|---|
Divestiture | Sign-up to View | ||
Add-on Acquisition | Sign-up to View | ||
Buyout (LBO, MBO, MBI) | Sign-up to View | ||
Total | Sign-up to View |
PE Firms (1) | Deals |
---|---|
Sign-up to View |
1 |
Corporate (2) | Deals |
---|---|
Sign-up to View |
1 |
Sign-up to View |
1 |
Value | # | TOTAL |
---|---|---|
> $1B | Sign-up to View | |
$100M to $1B | Sign-up to View | |
< $100M | Sign-up to View | |
TOTAL | Sign-up to View | |
Largest |
Ranbaxy Laboratories Ltd. $4.0B (2014-04-04) |